1Liver function tests were not a good predictor of hepatitis B infection.
2Ground glass cytoplasmic change in hepatocytes is typically associated with chronic hepatitis B infection.
3ARO-HBV is an RNAi therapeutic candidate for the treatment of chronic hepatitis B infection.
4The other patient acquired hepatitis B infection during the transplantation.
5All cases were negative for chronic hepatitis B infection.
6Elevated transaminases are more common in the presence of poor liver function and hepatitis B infection.
7HepaGam B was FDA-approved in January 2006 for preventing hepatitis B infection after various types of exposure.
8Of these, 53,000 or about 9 percent had evidence of hepatitis B infection.
9The incidence of liver cancer is higher in Asia partly due to a greater prevalence of hepatitis B infection.
10Aim: To investigate clinical factors associated with Hepatitis B screening and vaccination in patients at high-risk for Hepatitis B infection.
11Introduction and objectives: Universal vaccination at birth and in infancy is key to the elimination of chronic hepatitis B infection.
12Patients were considered high-risk for hepatitis B infection based on hepatitis B practice recommendations from the Center for Disease Control.
13Conclusion: The study reported a prevalence of 7.3% of occult hepatitis B infection.
14We noted that there was a significant difference in the prevalence of hepatitis B infection between regular and first time donors.
15Low haemoglobin levels and a history of hepatitis B infection were the most common factors for temporary and permanent donor deferrals, respectively.
16Overall, 44% of HCC cases worldwide were attributable to chronic hepatitis B infection, with the majority of cases occurring in Asia.
Translations for hepatitis b infection